ESR1 and breast carcinoma: The epigenetics of ERα re-expression in ERα-negative breast cancer cells has been studied in many laboratories, including our laboratory, and has been of intense interest as a novel strategy for the treatment of hormonal refractory breast cancer [4], [7], [25].